GE HealthCare 12 may 2026 GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Tools - The Globe and Mail
Pfizer 12 may 2026 Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu - Fierce Pharma
LabCorp 12 may 2026 Labcorp Integrates Full Diagnostic Menu into Epic Aura: Streamlining Lab Workflows for U.S. Health Systems - HIT Consultant
Vertex 12 may 2026 Vertex Pharma stock (US92532F1003): Earnings highlight pain drug advances - AD HOC NEWS
Eli Lilly 12 may 2026 Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report - Fierce Pharma
Qiagen 12 may 2026 Qiagen N.V. stock (NL0012169213): Proposes 40% dividend hike, appoints honorary chairman - AD HOC NEWS
Merck & Co. 12 may 2026 Merck & Co. stock (US58933Y1055): Oncology portfolio advances at ASCO 2026 - AD HOC NEWS
Samsung Biologics 12 may 2026 Samsung Biologics stock (KR7207940008): CDMO leader navigates South Korea biotech landscape - AD HOC NEWS
Pfizer 12 may 2026 BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial - Clinical Trials Arena
Novartis 12 may 2026 New prostate cancer hopes from Roche and Novartis | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline